XML 92 R27.htm IDEA: XBRL DOCUMENT v3.20.1
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
4 Months Ended 8 Months Ended 12 Months Ended
Dec. 31, 2018
Aug. 27, 2018
Dec. 31, 2019
Successor      
Numerator for basic and diluted net income (loss) per share:      
Net income (loss) attributable to Sanara MedTech $ 138,286   $ (2,814,088)
Series C preferred stock dividends 0   0
Series C Preferred Stock inducement dividends 0   0
Basic net income (loss) attributable to Sanara MedTech common shareholders $ 138,286   $ (2,814,088)
Denominator for basic and diluted net income (loss) per share      
Weighted average shares used in computing diluted net income (loss) per share 0   2,132,745
Basic and diluted net income (loss) per share attributable to common shareholders $ 0   $ (1.32)
Predecessor      
Numerator for basic and diluted net income (loss) per share:      
Net income (loss) attributable to Sanara MedTech   $ 37,178  
Series C preferred stock dividends   (28,061)  
Series C Preferred Stock inducement dividends   (103,197)  
Basic net income (loss) attributable to Sanara MedTech common shareholders   $ (94,080)  
Denominator for basic and diluted net income (loss) per share      
Weighted average shares used in computing diluted net income (loss) per share   2,068,941  
Basic and diluted net income (loss) per share attributable to common shareholders   $ (0.05)